|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
52808745
線上人數 :
583
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 547271-547280 / 2348719 (共234872頁)
<< < 54723 54724 54725 54726 54727 54728 54729 54730 54731 54732 > >>
每頁顯示[10|25|50]項目
| 國立臺灣海洋大學 |
2013 |
Lemon protein disulfide isomerase: cDNA cloning and biochemical characterization
|
Yu-Ting Chen;Lisa Wen;Kuo-Chuan Ho;Rong-Huay Juang;Chi-Tsai Lin |
| 臺大學術典藏 |
2020-01-06T03:09:14Z |
Lemon protein disulfide isomerase: cDNA cloning and biochemical characterization
|
Chen, Y.-T.; Wen, L.; Ho, K.-C.; Juang, R.-H.; Lin, C.-T.; KUO-CHUAN HO |
| 朝陽科技大學 |
2006 |
Lempel-Ziv資料壓縮方法之抗錯研究
|
曾顯文 |
| 中國醫藥大學 |
2014-07-17 |
LEM避免UVA誘導的氧化傷害及促進皮膚細胞增生和遷移之機制探討
|
蔡喻丞;Yu-Cheng Tsai |
| 國立臺灣大學 |
2016 |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration
|
Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 林宗哲; 鄭安理; 陳邦斌; 徐志宏; 許駿 |
| 臺大學術典藏 |
2020-04-10T12:16:00Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration
|
YU-YUN SHAO; Chen B.-B.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Hsu C. |
| 臺大學術典藏 |
2018-09-10T18:05:00Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao, Y.-Y.;Chen, B.-B.;Ou, D.-L.;Lin, Z.-Z.;Hsu, C.-H.;Wang, M.-J.;Cheng, A.-L.;Hsu, C.; BANG-BIN CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2020-04-10T12:51:01Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao Y.-Y.;Chen B.-B.;Ou D.-L.;Lin Z.-Z.;Hsu C.-H.;Wang M.-J.;Cheng A.-L.;Chiun Hsu; Shao Y.-Y.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Chiun Hsu |
| 臺大學術典藏 |
2020-04-28T07:25:13Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao Y.-Y.; Shao Y.-Y.;Chen B.-B.;Ou D.-L.;Lin Z.-Z.;Chih-Hung Hsu;Wang M.-J.;Cheng A.-L.;Hsu C.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; CHIH-HUNG HSU; Wang M.-J.; Cheng A.-L.; Hsu C. |
| 臺大學術典藏 |
2021-08-31T06:29:34Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao Y.-Y.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; ANN-LII CHENG; Hsu C. |
顯示項目 547271-547280 / 2348719 (共234872頁)
<< < 54723 54724 54725 54726 54727 54728 54729 54730 54731 54732 > >>
每頁顯示[10|25|50]項目
|
